Psilocybin and Escitalopram Show Distinct Brain Effects in Depression Treatment
June 11, 2025
A new randomized controlled trial directly compared the brain effec...
Read More
Trial Results of Solriamfetol in MDD With/Without Excessive Daytime Sleepiness
May 18, 2025
A new phase 3 proof-of-concept trial offers early evidence that sol...
Read More
Accelerated Theta-Burst Stimulation for Treatment-Resistant Depression
April 14, 2025
A recent study provides compelling evidence supporting the use of a...
Read More
New Research Links Depression to Increased Risk of Multiple Chronic Diseases
March 27, 2025
Mood disorders are increasingly viewed as whole-body conditions aff...
Read More
New Insights into Esketamine Treatment: Efficacy, Safety, and Long-Term Effects
March 4, 2025
Intranasal esketamine has been approved as an adjunctive pharmacoth...
Read More
Deprescribing Antidepressants in Children and Adolescents
March 3, 2025
When considering the discontinuation of antidepressant treatment, f...
Read More
Associations Between Biomarkers of Inflammation and Depressive Symptoms
February 7, 2025
A recent study published in Translational Psychiatry has provided ...
Read More
Depressive Symptoms and Amyloid Pathology
February 1, 2025
A recent large-scale study examined the association between depress...
Read More
Effectiveness of Antidepressant Treatments In TRD
January 10, 2025
A comprehensive network meta-analysis recently published offers new...
Read More
The Role of Inflammation in Mental Health
November 9, 2024
Inflammation triggers chemical reactions in the body that can direc...
Read More
Medication-Induced Weight Change Across Common Antidepressant Treatments
October 9, 2024
While antidepressants rank among the most frequently prescribed dru...
Read More
Inflammatory Biomarkers and Risk of Psychiatric Disorders
October 5, 2024
A recent study investigates whether certain inflammatory markers i...
Read More